Adult Male Hypogonadism

Endocrinology
3
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
3
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Ferring Pharmaceuticals
Ferring PharmaceuticalsArgentina - Buenos Aires
3 programs
3
Testosterone GelPhase 31 trial
Testosterone gelPhase 31 trial
Testosterone gelPhase 31 trial
Active Trials
NCT01703741Completed145Est. Oct 2013
NCT01665599Completed180Est. May 2013
NCT02149264Completed160Est. Jun 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Ferring PharmaceuticalsTestosterone gel
Ferring PharmaceuticalsTestosterone Gel
Ferring PharmaceuticalsTestosterone gel

Clinical Trials (3)

Total enrollment: 485 patients across 3 trials

A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males

Start: Jul 2014Est. completion: Jun 2015160 patients
Phase 3Completed

A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel

Start: Dec 2012Est. completion: Oct 2013145 patients
Phase 3Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel

Start: Jul 2012Est. completion: May 2013180 patients
Phase 3Completed

Related Jobs in Endocrinology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space